Analyst Information for Novavax Inc.

$ 9.22   1.27 (+15.97%) Volume: 25.29m 4:00 PM EST 26-Feb-2020
After Hours:  $ 10.15   0.93 (+10.09%) Volume: 580.48k 7:59 PM EST 26-Feb-2020
Consensus Rating Average
Consensus Rating for NVAX is MODERATE BUY
Since many brokers have different rating systems, we maintain a standard system with an assigned numeric value from 1 to 5. Ratings are a translation of brokers' recommendations to the recommendation scale, which ranges from a rating of 1 (a strong buy) to a rating of 5 (a strong sell).
Rating Scale
Strong Buy 1.0 - 1.5
Moderate Buy 1.6 - 2.5
Hold 2.6 - 3.5
Moderate Sell 3.6 - 4.5
Strong Sell 4.6 - 5.0
Consensus Rating Details
Current Average Recommendation 2.00
Previous Average Recommendation 2.00
Change in Average Recommendation 0.00
Number of Analysts Reporting 8
Strong Buy
1.0
Current: 2.00
Previous: 2.00
Change: 0.00
Strong Sell
5.0
Consensus Rating Industry Comparison
Industry: MED-BIOMED/GENE
Number of companies in industry with recommendations 375
Rank Recommendation relative to companies in its industry 326
Ranked 326 in Industry
1375 MED-BIOMED/GENE
Analyst Recommendations
Analysts recommending Strong Buy 5
Analysts recommending Moderate Buy 0
Analysts recommending Hold 2
Analysts recommending Moderate Sell 0
Analysts recommending Strong Sell 1
Vertical Bar Chart
Recommendations History
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 5
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.00 2.00 2.00 2.00

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.    RT = Real-Time,  EOD = End Of Day,  PD = Previous Day.   Market Data powered by QuoteMedia. Analyst ratings by Zacks.   Terms of Use.